Hallucinogen DMT an effective antidepressant in small clinical trial
Summary
Ars Technica reports on a small London clinical trial examining single-dose DMT for depression, showing rapid improvement in treated participants versus placebo at one week and lasting benefits through 14 weeks with mild, temporary side effects. The study links antidepressant effects to subjective mystical experiences, raising questions about blinding and the need for larger trials to confirm efficacy and safety.